Objectives: To determine safety and efficacy of the 5HT1A serotonin partial agonist buspirone on core autism and associated features in children with autism spectrum disorder (ASD).
Study Design: Children 2-6 years of age with ASD (N = 166) were randomized to receive placebo or 2.5 or 5.
Objective: This study tested the hypothesis that gender differences in parent-reported nurturance of children would be attenuated in families of children with neurodevelopmental conditions (NDCs).
Method: In this cross-sectional study, participants included 49 (29 male) children diagnosed with an NDC and 60 (30 male) typically developing (TD) children. Children in the NDC group had a diagnosis of cerebral palsy (CP; n = 41) or spina bifida (SB; n = 8).
This study was conducted to demonstrate feasibility of utilizing a modified SEIQoL-DW with children by examining self-generated domains of quality of life in children with and without cerebral palsy. Study samples were children, ages 6-12, (mean 8.9, SD 1.
View Article and Find Full Text PDFObjective: To examine the associations between parenting dimensions and the social functioning of children with and without cerebral palsy (CP). The primary hypothesis was that controlling for cognitive ability, specific parenting dimensions would be associated with higher social functioning, including larger social networks, higher-quality friendships, and healthier social adjustment in children with and without CP.
Participants: Forty-one children with cerebral palsy and 60 typically developing (TD) children, ages 6 to 12.